Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
NLS Pharmaceutics ( (NLSP) ) has issued an update.
NLS Pharmaceutics, a company based in Zurich, Switzerland, has scheduled an extraordinary shareholders’ meeting to discuss significant capital increases. The board proposes to increase the company’s share capital through a series of ordinary capital increases related to a private investment in public equity (PIPE) transaction and additional financing tranches. This move aims to raise capital flexibly and quickly as part of a restructuring measure, impacting shareholder rights and potentially enhancing the company’s strategic financing capabilities.
More about NLS Pharmaceutics
YTD Price Performance: -92.12%
Average Trading Volume: 350,360
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.6M
For a thorough assessment of NLSP stock, go to TipRanks’ Stock Analysis page.
